SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-052939
Filing Date
2021-08-23
Accepted
2021-08-23 16:07:57
Documents
1
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2227
  Complete submission text file 0001209191-21-052939.txt   3845
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 415-655-4899
EISA-ABC LLC (Reporting) CIK: 0001878914 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39990 | Film No.: 211196933